Previous studies have demonstrated that regulatory T cells (Tregs) play a protective role in the pathogenesis of chronic graft-versus-host disease (cGVHD). Tregs constitutively express the gene of the transcription factor Foxp3 whose CNS2 region is heavily methylated in conventional CD4(+) T cells (CD4(+)Tconvs) but demethylated in Tregs.status: publishe
Chronic allograft dysfunction (CAD) in solid organ transplantation is a principal cause of patient m...
International audienceFOXP3+ regulatory T cell (Treg) based cellular therapies represent promising t...
Acute graft-versus-host disease (aGvHD) is a frequent complication after allogeneic bone marrow/stem...
Introduction: Graft-versus-host disease (GVHD) has remained a major complication of allogeneic hemat...
Introduction: Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoie...
Background. The demethylating agent 5-azacytidine (AZA) has proven its efficacy as treatment for mye...
The demethylating agent 5-azacytidine (AZA) has proven its efficacy in the treatment of myelodysplas...
Introduction: Graft-versus-host disease (GVHD) remains one major complication of allogeneic hematopo...
The demethylating agent 5-azacytidine (AZA) has proven its efficacy in the treatment of myelodysplas...
The demethylating agent 5-azacytidine (AZA) has proven its efficiency in myeloid malignancies treatm...
CD4+FOXP3+ regulatory T cells have demonstrated efficacy in graft-versus-host disease (GvHD) prevent...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffer...
Regulatory T cells (Tregs) that constitu-tively express FOXP3 are instrumental to the maintenance of...
Regulatory T (Tregs) cells play a crucial role in immunoregulation and promotion of immunological to...
Chronic allograft dysfunction (CAD) in solid organ transplantation is a principal cause of patient m...
International audienceFOXP3+ regulatory T cell (Treg) based cellular therapies represent promising t...
Acute graft-versus-host disease (aGvHD) is a frequent complication after allogeneic bone marrow/stem...
Introduction: Graft-versus-host disease (GVHD) has remained a major complication of allogeneic hemat...
Introduction: Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoie...
Background. The demethylating agent 5-azacytidine (AZA) has proven its efficacy as treatment for mye...
The demethylating agent 5-azacytidine (AZA) has proven its efficacy in the treatment of myelodysplas...
Introduction: Graft-versus-host disease (GVHD) remains one major complication of allogeneic hematopo...
The demethylating agent 5-azacytidine (AZA) has proven its efficacy in the treatment of myelodysplas...
The demethylating agent 5-azacytidine (AZA) has proven its efficiency in myeloid malignancies treatm...
CD4+FOXP3+ regulatory T cells have demonstrated efficacy in graft-versus-host disease (GvHD) prevent...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffer...
Regulatory T cells (Tregs) that constitu-tively express FOXP3 are instrumental to the maintenance of...
Regulatory T (Tregs) cells play a crucial role in immunoregulation and promotion of immunological to...
Chronic allograft dysfunction (CAD) in solid organ transplantation is a principal cause of patient m...
International audienceFOXP3+ regulatory T cell (Treg) based cellular therapies represent promising t...
Acute graft-versus-host disease (aGvHD) is a frequent complication after allogeneic bone marrow/stem...